Syncope and All-Cause Mortality in Heart Failure: A Propensity Score–Matched Analysis
Objective: To examine the association between syncope and all-cause mortality in a large cohort of patients with heart failure (HF) with syncope. Patients and Methods: We retrospectively identified a cohort of patients with HF and syncope from January 1, 2010, to December 31, 2015, and matched them...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Mayo Clinic Proceedings: Innovations, Quality & Outcomes |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2542454825000311 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Objective: To examine the association between syncope and all-cause mortality in a large cohort of patients with heart failure (HF) with syncope. Patients and Methods: We retrospectively identified a cohort of patients with HF and syncope from January 1, 2010, to December 31, 2015, and matched them in a 1:1 propensity analysis with patients with HF without syncope. A multivariable Cox regression model was used to estimate the association between syncope and the end point, all-cause mortality. Results: During the study period, 3449 patients with HF were diagnosed with syncope (mean ± SD age, 72.8±14.3 years). At 12 months follow-up, syncope was not an independent risk factor of all-cause mortality in overall patients with HF (hazard ratio [HR], 0.98; 95% CI, 0.91-1.04; P=.467), HF with preserved ejection fraction (EF) (HR, 1.02; 95% CI, 0.93-1.11; P=.686), HF with mid-range EF (HR, 0.92; 95% CI, 0.73-1.16; P=.494), or HF with reduced EF (HR, 0.94; 95% CI, 0.83-1.06; P=284). In the subgroup of those with cardiac implantable electronic devices, syncope significantly increased the risk of all-cause mortality in HF with reduced EF (HR, 1.28; 95% CI, 1.01-1.62; P=.038). Conclusion: Syncope was not an independent risk of all-cause mortality for patients with HF but significantly predicted the all-cause mortality in the subgroup of patients with heart failure reduced EF with cardiac implantable electronic devices. |
|---|---|
| ISSN: | 2542-4548 |